| scholarly article | Q13442814 |
| P50 | author | Andréa Barbosa de Melo | Q117232797 |
| Alessandro Sette | Q28324161 | ||
| Ernesto T A Marques | Q62676198 | ||
| Marli T Cordeiro | Q63375188 | ||
| John Sidney | Q88013439 | ||
| Robbie B. Mailliard | Q37387135 | ||
| P2093 | author name string | Asif M Khan | |
| J Thomas August | |||
| Charles Rinaldo | |||
| Eduardo J M Nascimento | |||
| Françoir Lemonnier | |||
| Laura V G Gil | |||
| Michael Paulaitis | |||
| Nicole Guzman | |||
| P2860 | cites work | Conservation and variability of dengue virus proteins: implications for vaccine design | Q24288762 |
| NS5 of dengue virus mediates STAT2 binding and degradation | Q24644381 | ||
| Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections | Q27469477 | ||
| Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection | Q27469545 | ||
| Large-scale analysis of antigenic diversity of T-cell epitopes in dengue virus | Q27477942 | ||
| Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones | Q27480380 | ||
| Differential Functional Avidity of Dengue Virus-Specific T-Cell Clones for Variant Peptides Representing Heterologous and Previously Encountered Serotypes | Q27481452 | ||
| A single nine-amino acid peptide induces virus-specific, CD8+ human cytotoxic T lymphocyte clones of heterogeneous serotype specificities | Q27485111 | ||
| Humidity control as a strategy for lattice optimization applied to crystals of HLA-A*1101 complexed with variant peptides from dengue virus | Q27485892 | ||
| Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone | Q27486071 | ||
| Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice model | Q27487555 | ||
| Severe Dengue Epidemics in Sri Lanka, 2003–2006 | Q27488269 | ||
| A Protective Role for Dengue Virus-Specific CD8+ T Cells | Q27488347 | ||
| The Incidence, Characteristics, and Presentation of Dengue Virus Infections during Infancy | Q27490855 | ||
| T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs | Q28485408 | ||
| Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial | Q29616259 | ||
| Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever | Q29619585 | ||
| Prospects for a dengue virus vaccine | Q29619608 | ||
| Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. | Q30384675 | ||
| Optimized determination of T cell epitope responses | Q31133720 | ||
| Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method | Q33289831 | ||
| Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries | Q33316579 | ||
| NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction | Q33504888 | ||
| Dendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice | Q33522216 | ||
| Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity | Q33530024 | ||
| Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission | Q33573378 | ||
| Dengue fever caused by dengue virus serotype-3 (subtype-III) in a rural area of Madurai district, Tamil Nadu | Q42999990 | ||
| HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus | Q44282212 | ||
| Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization | Q45150958 | ||
| Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice | Q47817045 | ||
| Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices | Q57221639 | ||
| Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice | Q72049883 | ||
| alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity | Q80516665 | ||
| Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology | Q33610555 | ||
| Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength | Q34062468 | ||
| Dengue virus surveillance for early warning, Singapore | Q34194030 | ||
| CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination | Q34234563 | ||
| Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. | Q34487794 | ||
| Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. | Q35002940 | ||
| Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil | Q35246149 | ||
| Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design | Q35268996 | ||
| Mice lacking all conventional MHC class II genes | Q35620743 | ||
| Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human Population | Q35839141 | ||
| Reverse Vaccinology: Developing Vaccines in the Era of Genomics | Q35873940 | ||
| Dengue vaccines: problems and prospects. | Q36152622 | ||
| West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands | Q36155428 | ||
| HLA class I transgenic mice: development, utilisation and improvement | Q36194073 | ||
| A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults | Q36523070 | ||
| Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). | Q36666340 | ||
| Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes | Q36766285 | ||
| Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches | Q36899098 | ||
| HLA-B∗44 Is Associated with Dengue Severity Caused by DENV-3 in a Brazilian Population | Q36933241 | ||
| Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes | Q37066897 | ||
| Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore | Q37694849 | ||
| Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms | Q37901360 | ||
| HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis | Q38357177 | ||
| Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses | Q39176711 | ||
| T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? | Q39263024 | ||
| Measurement of MHC/peptide interactions by gel filtration | Q39989093 | ||
| Dengue virus inhibits the production of type I interferon in primary human dendritic cells | Q40338983 | ||
| Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects | Q40410592 | ||
| Dengue and dengue hemorrhagic fever in the State of Pernambuco, 1995-2006. | Q40429365 | ||
| Characterization of a dengue patient cohort in Recife, Brazil. | Q40430488 | ||
| Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3). | Q40480637 | ||
| Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes | Q40485716 | ||
| Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes | Q40502077 | ||
| Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand | Q40539101 | ||
| Serotype-specific T(H)1 responses in recipients of two doses of candidate live-attenuated dengue virus vaccines | Q40541503 | ||
| T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity | Q40581865 | ||
| Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4. | Q40642576 | ||
| Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones | Q40646852 | ||
| Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport | Q40665490 | ||
| HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice | Q41903577 | ||
| Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination | Q42238546 | ||
| Dengue virus serotype 3 subtype III, Zhejiang Province, China | Q42953132 | ||
| Definition of the region on NS3 which contains multiple epitopes recognized by dengue virus serotype-cross-reactive and flavivirus-cross-reactive, HLA-DPw2-restricted CD4+ T cell clones | Q42987713 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DENV-3 | Q106250534 |
| P304 | page(s) | e2497 | |
| P577 | publication date | 2013-10-10 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Identification of conserved and HLA promiscuous DENV3 T-cell epitopes | |
| P478 | volume | 7 |
| Q66679555 | A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice |
| Q41929458 | A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles |
| Q45325923 | A novel multi-variant epitope ensemble vaccine against avian leukosis virus subgroup J. |
| Q38605194 | Analysis of cell-mediated immune responses in support of dengue vaccine development efforts |
| Q47555471 | Analysis of viral diversity for vaccine target discovery |
| Q30384608 | CD4+ T-cell epitope prediction using antigen processing constraints |
| Q99589393 | Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine |
| Q35886539 | Dengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals |
| Q40038715 | Development of Peptide Vaccines in Dengue. |
| Q41928044 | How Can Elispot Add Information to Improve Knowledge on Tropical Diseases? |
| Q90266052 | Human T Cell Response to Dengue Virus Infection |
| Q38934962 | Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2. |
| Q51336680 | Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development. |
| Q40188864 | In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes |
| Q40160412 | Structural Basis for CD4+ T Cell Epitope Dominance in Arbo-Flavivirus Envelope Proteins: A Meta-Analysis. |
| Q66679253 | T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification |
| Q38640293 | T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity |
| Q47554119 | T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses. |
| Q35880666 | The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice |
| Q37365222 | Towards the knowledge-based design of universal influenza epitope ensemble vaccines |
Search more.